Oricula Therapeutics is a start-up biotechnology company with a mission to develop medicines that protect hearing and balance from the effects of ototoxic drugs and aging. They have developed the first medication to prevent hearing loss in patients undergoing treatment for serious infections with aminoglycoside antibiotics.